Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahmed, S. B.
Right arrow Articles by Miller, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahmed, S. B.
Right arrow Articles by Miller, J. A.
J Am Soc Nephrol 15:780-786, 2004
© 2004 American Society of Nephrology


CLINICAL SCIENCE

Effects of Oral Contraceptive Use on the Renal and Systemic Vascular Response to Angiotensin II Infusion

Sofia B. Ahmed, Amrit K. Kang, Kevin D. Burns, Christopher R. J. Kennedy, Vesta Lai, Daniel C. Cattran, James W. Scholey and Judith A. Miller

Division of Nephrology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada

Correspondence to Dr. Judith A. Miller, Division of Nephrology, 11EN-221, Toronto General Hospital, University Health Network, 200 Elizabeth Street, Toronto, Ontario, Canada, M5G 2C4. Phone: 416-340-4966; Fax: 416-340-4951; E-mail: judith.miller{at}utoronto.ca

ABSTRACT. We have previously shown that users of oral contraceptive (OC) medications exhibit increased plasma levels of angiotensin II (Ang II) with only modest hemodynamic consequences, suggesting estrogen-mediated Ang II type 1 (AT1) receptor downregulation. Accordingly, in 10 women who were OC users and 10 women who, as OC nonusers, served as controls, all mean age 26 ± 1 yr, we examined the renal and peripheral hemodynamic response to graded Ang II infusion, plasma and urine cyclic guanosine monophosphate (cGMP) levels as a surrogate marker for AT1 and/or AT2 receptor-mediated activation of the nitric oxide pathway, and AT1 receptor expression in skin biopsies. The OC nonusers were studied during the follicular and luteal phases of the menstrual cycle, whereas OC users were studied once during the 21-d medication phase. Subjects ingested a controlled sodium diet for 7 d before each study. Renal hemodynamic function was assessed using standard inulin and p-aminohippurate clearance techniques. AT1 receptor mRNA levels in skin biopsy samples were assessed using a real-time PCR protocol. In response to graded Ang II infusion, OC users exhibited renal and peripheral hemodynamic responses that were augmented compared with those of OC nonusers, in conjunction with evidence of increased tissue AT1 receptor expression. Plasma cGMP levels and 24-h urinary cGMP excretion did not differ. These data suggest that, contrary to our original hypothesis, OC use does not appear to be associated with AT1 receptor downregulation. The factor protecting OC users from the hemodynamic impact of increased Ang II levels remains elusive.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Z. I. Cherney, J. W. Scholey, R. Nasrallah, M. G. Dekker, C. Slorach, T. J. Bradley, R. L. Hebert, E. B. Sochett, and J. A. Miller
Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1336 - F1341.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Z. I. Cherney, J. W. Scholey, D. C. Cattran, A. K. Kang, J. Zimpelmann, C. Kennedy, V. Lai, K. D. Burns, and J. A. Miller
The effect of oral contraceptives on the nitric oxide system and renal function
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1539 - F1544.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. A. Miller, D. Z. Cherney, J. A. Duncan, V. Lai, K. D. Burns, C. R.J. Kennedy, J. Zimpelmann, W. Gao, D. C. Cattran, and J. W. Scholey
Gender Differences in the Renal Response to Renin-Angiotensin System Blockade
J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2554 - 2560.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. B. Ahmed, P. Hovind, H.-H. Parving, P. Rossing, D. A. Price, L. M. Laffel, M. C. Lansang, R. Stevanovic, N. D.L. Fisher, and N. K. Hollenberg
Oral Contraceptives, Angiotensin-Dependent Renal Vasoconstriction, and Risk of Diabetic Nephropathy
Diabetes Care, August 1, 2005; 28(8): 1988 - 1994.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP